CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

/ 2
Filters:
Show search box
2012-11-08
BIOMAX SA - receives a positive assessment of the project financing application

BIOMAX SA - receives a positive assessment of the project financing application

The Polish biotech company BIOMAX SA - received information from the National Center for Research and Development about a positive assessment of the proposal for funding of the company's project: "Development of innovative manufacturing technology of a new generation of cosmetics and dietary suppleme... Read more
Tags biotechnology , poland , interview
2012-10-15 to 2012-10-18
Penta sells Alpha Medical laboratories

Penta sells Alpha Medical laboratories

Penta Investments, the Central European investment group, has signed an agreement to sell 100% stake in Alpha medical a.s. and Alpha medical Polska Sp. z o.o. to Mid Europa Partners. The transaction includes the whole Alpha Medical group and its assets in the Czech Republic, Slovakia and Poland. Alph... Read more
Tags poland , czech republic , europe , slovakia
“This place is the real answer to the actual needs of the polish economy”

“This place is the real answer to the actual needs of the polish economy”

The President of the Republic of Poland said that about the BioNanoPark that has been officially opened today at 10am in Lodz. The President of the Republic of Poland, Bronisław Komorowski accompanied by the Minister of Health, Minister of Regional Development, the President of Lodz and rectors of th... Read more
Tags biotechnology , poland , nanotechnology
2012-10-10
Mabion starts clinical trials in Serbia

Mabion starts clinical trials in Serbia

Mabion SA – polish biotech company – submitted to the Serbian Ministry of Health all the scientific and legal documentation required to register the clinical trials of MabionCD20 – a drug that is to be used in blood cancer and rheumatoid arthritis treatment. Serbia is the second of all 8 selected Eur... Read more
Tags biotechnology , poland , medicine , europe
2012-09-25
Will Euroimplant S.A. revolutionize the aesthetic medicine market?

Will Euroimplant S.A. revolutionize the aesthetic medicine market?

Polish biotechnology company Euroimplant S.A. has launched a new service based on a method of isolation of ADSC - Adipose Derived Steam Cells, which was developed by the research team of the company and is performed basing on a certificate of the Polish Ministry of Health.... Read more
Tags biotechnology , poland
2012-09-19
BioForum 2013, Budapest

BioForum 2013, Budapest

We live and work in Central Europe. Our region is formed by countries recentlyliberated from a totalitarian communist regime. We have common cultural and historical roots and face similar social, political and economic problems. One of our common strategic goals is to quickly make up for the technol... Read more
Tags bioforum , poland , interview , hungary
2012-08-14
 Euroimplant S.A. serves new solutions for regenerative medicine and cosmetics

Euroimplant S.A. serves new solutions for regenerative medicine and cosmetics

Euroimplant S. A. has recently gained a patent concerning their newest inventions – the “Bioreaktor”. The invention is adjusted to tissue engineering (e.g. 3D cell culture) and in vivo toxicology as well as many other biotechnological applications.... Read more
Tags biotechnology , poland , medicine
2012-07-23
Genomed co. gets a million!

Genomed co. gets a million!

The new projet of the co-partnership considering “Utilization of genomic diagnostics in development of personalized medicine” gets a sponsor - the Polish Agency of Enterprise Development (pol. Polska Agencja Rozwoju Przedsiębiorczości, PARP). The funding reaches nearly a million EUR (about 3 mio PLN)... Read more
Tags biotechnology , poland , interview
2012-06-26
Mabion explores Turkish market!

Mabion explores Turkish market!

Mabion co. – Polish biotech company runing research on biosimilar pharmaceuticals– has signed an intent letter on cooperation with Turkish pharma company in terms of introduction of MabionCD20 medicine to the Turkish market. Annual income from sales of MabThera – the reference of MabionCD20 – in Turk... Read more
Tags biotechnology , poland , pharma
2012-05-30
 Polish biotech company – Mabion co. – sells pharmaceuticals to Northern Africa

Polish biotech company – Mabion co. – sells pharmaceuticals to Northern Africa

Mabion co. – Polish company specialized in medical biotechnology; created to implement research and biosimilar drugs – has recently singed a letter of intent with Sothema Laboratories, company from Marocco, in terms of distribution of the MabionCD20 pharmaceutical in the Maghreb countries (Marocco, A... Read more
Tags biotechnology , poland , pharma
2012-03-05
Inno-Gene competes in the American market

Inno-Gene competes in the American market

CB DNA and NewLab Systems, co-partnerships of Inno-Gene Ltd., have recently signed an agreement with an American company, Caliper Life Sciences, Hopkinton-Massachusetts, concerning distribution of innovative laboratory systems in the Polish market.... Read more
Tags biotechnology , poland
2012-02-27
 JCI Venture bets on the red biotechnology

JCI Venture bets on the red biotechnology

The investment portfolio of the JCI Venture fund added an innovative biotechnological company, simAb co. The co-partnership will be active in the biotechnological drugs sector, working on new therapies against tumor and metabolic conditions, which afflict millions of patients. The team of originators... Read more
Tags poland , pharma
2012-02-20 to 2012-02-24
Biotechnological drug Prolia® rewarded as the Innovation for Health 2011

Biotechnological drug Prolia® rewarded as the Innovation for Health 2011

On January 2012 the Innovation for Health contest was completed. Drug companies, patient associations, drugs, hospitals and foundations could have been rewarded in one of the following categories: prophylaxis, education and promotion of patient activity, management, medical technologies and equipment... Read more
Tags biotechnology , poland , pharma
Mabion achieves a record income

Mabion achieves a record income

Polish company, Mabion co., obtained over 4.1 mio PLN (1 mio EUR) sales income in the 4th quarter of 2011. After four quarters sales of the company was increasingly accounting for 10.5 mio PLN (2.5 mio EUR). It is over 7.4 mio PLN (1.8 mio EUR) more than after 2010.... Read more
Tags biotechnology , poland
Stem Cells Spin co. obtained two new patents and enters the market with first products!

Stem Cells Spin co. obtained two new patents and enters the market with first products!

Stem Cells Spin co., a company from Wroclaw, Poland, is confidently approaching success in realization of its business plans. The company has recently obtained two new patents, which strengthen its position while entering the market with products of unique characteristics.... Read more
Tags biotechnology , poland
2012-02-15 to 2012-02-17
Cormay co. awarded as the most successful and the most prospective company 2011

Cormay co. awarded as the most successful and the most prospective company 2011

Cormay co. was granted for the greatest success and the best future perspectives among other co-partnerships in “The Best Co-partnership in the Stock Market” plebiscite. Today it is one of the most dynamically developing Polish companies dealing with molecular diagnostics. Its fast expansion in forei... Read more
Tags poland , medicine
BioMaxima confirms its strong position in business

BioMaxima confirms its strong position in business

Quoted BioMaxima co. consequently strengthens its leading position within Polish biotechnology companies. Enormous profits turned by the company in the 4th quarter of 2011 clearly indicate its dynamic development.... Read more
Tags biotechnology , poland
2012-02-09
CB DNA cancer diagnostic test hailed as the Innovation 2011

CB DNA cancer diagnostic test hailed as the Innovation 2011

Innovations for Health 2011 Award granted to the DNA Research Centre (Centrum Badań DNA, CB DNA) for the diagnostic test in terms of susceptibility to colon cancer. CB was awarded by the Innovation in Healthcare Group (Grupa Robocza na Rzecz Innowacji w Opiece Zdrowotnej) in Prophylaxis category.... Read more
Tags poland
2012-01-29
Selvita 1st in Deloitte Technology Fast 50 Central Europe 2011

Selvita 1st in Deloitte Technology Fast 50 Central Europe 2011

“We would like to become one of the globally recognised drug discovery service providers, achieving a stable increase in revenues and profits from services rendered to pharmaceutical companies and R&D laboratories” - says Paweł Przewięźlikowski, CEO... Read more
Tags bioforum , biotechnology , poland